Why Zacks? Learn to Be a Better Investor.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.
If you wish to go to ZacksTrade, click
OK. If you do not, click Cancel.
Back to top
Gentiva Health Services Inc. reported first-quarter 2013 operating earnings of 23 cents per share, which lagged the Zacks Consensus Estimate of 31 cents as well as the year-ago quarter level of 24 cents per share. Operating income of $7.1 million also declined from $7.4 million in the year-ago quarter.
Including a non-cash impairment charge of $224.3 million related to goodwill and other long-lived assets, along with restructuring, legal settlement and acquisition and integration costs of $0.14 million, Gentiva posted a net loss of $207.2 million or $6.73 per share, compared with net income of $4.8 million or 16 cents per share in the first quarter of 2012.
Gentiva’s net revenue declined 5% year over year to $415.6 million from $435.7 million in the year-ago quarter. Net revenue also missed the Zacks Consensus Estimate of $428 million. The year-over-year decline was largely due to a significant cut in the home health Medicare rates along with the impact of sequestration and sale and closure of some branches.
The Home Health Episodic segment revenues declined 2% year over year to $207.4 million. Additionally, the Hospice segment revenues declined 8% year over year to $179.5 million.
Adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) attributable to continuing operations decreased 6.7% to $39.1 million from $41.9 million in the prior-year quarter. Financial Update
Gentiva exited the reported quarter with cash and cash equivalents of approximately $159.6 million, down from $207.1 million as of Dec 31, 2012. Outstanding debt was $910.2 million, down from $935.2 million at 2012 end.
During the reported quarter, net cash used in operating activities amounted to $20.6 million, narrower than the cash outflow of $34.7 million in the prior-year period. Free cash flow also narrowed to ($23.3) million from ($38.5) million in the first-quarter of 2012.
As of Mar 31, 2013, Gentiva had total assets of $1.24 billion and shareholder equity of $29.6 million, as compared with $1.51 billion and $234.7 million, respectively, as of Dec 31, 2012. Outlook
Gentiva’s net revenue guidance for 2013 stands at $1.69–$1.73 billion. This guidance includes a negative impact of $21 million from the sale and closure of branches in 2012. The company expects adjusted income from continuing operations between 90 cents and $1.10 per share, calculated on the basis of 31 million outstanding shares. Zacks Rank
Gentiva carries a Zacks Rank #5 (Strong Sell). Another healthcare company DaVita HealthCare Partners Inc. ( DVA - Analyst Report) reported first-quarter 2013 operating earnings of $1.84 per share, beating the Zacks Consensus Estimate of $1.78 as well as $1.50 per share reported in the prior-year quarter.
Other healthcare companies worth considering are Addus HomeCare Corporation ( ADUS - Snapshot Report) and HEALTHSOUTH Corp. ( HLS - Snapshot Report) . Both these companies carry a Zacks Rank #1 (Strong Buy).